Ryan Martindell, Associate, Joins Houlihan Capital’s Valuation & Financial Advisory Group

Houlihan Capital is pleased to announce our newest addition to the team, Ryan Martindell, as Associate in Houlihan Capital’s Valuation & Financial Group. Mr. Martindell performs valuations for financial reporting (ASC 820, 718, 805, and 350), tax, strategic planning, and transaction opinion (fairness, solvency, and capital adequacy) purposes. His responsibilities include conducting due diligence, performing […]

SPACs – Proposed New Rules by the SEC

The SEC recently proposed new rules and amendments intended to enhance investor protections in initial public offerings by special purpose acquisition companies (“SPACs”) and in subsequent business combination transactions between SPACs and private operating companies. If adopted, the rules would impact SPACs in a variety of important ways. Below we summarize and comment upon the […]

Houlihan Capital Advised on the Recapitalization of DocMJ by Chatham Capital

Houlihan Capital’s Investment Banking Group is pleased to announce the following transaction: October 2021 Recapitalization of DocMJ Debt & Equity Provided by Chatham Capital Sector: Ancillary Services – Cannabis Houlihan Capital acted as the exclusive financial advisor to DocMJ, the leading group of medical marijuana doctors in the state of Florida, on its recapitalization through […]

Quarterly Industry Report Updates are Available for Q1 2022

Houlihan Capital provides Quarterly Updates on the following industries as of March 31, 2022. Information includes valuation metrics, performance data and M&A activity. Click on the following links below to access reports for the following industries: Aerospace, Defense & Government Asset Management Banking Building Products Business Services Cannabis Chemicals Consumer Products Internet Retail Media and […]